New CAR T cell therapy targets chronic blood cancer cells while sparing healthy cells
A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving…
Read the full article15d ago3 min readenNews
You might also wanna read
GE HealthCare and Mayo Clinic launch theranostics study to personalize prostate cancer treatment
mayocl.in·8d ago
Molecular tumor boards show promise in bridging precision oncology's translation gap
plos.io·15d ago
Phase 3 trial: PSMA-PET-CT may help some high-risk men avoid prostate biopsy
mdsc.pe·16d ago
Mayo Clinic Study Maps Meningioma Tumor Environment, Revealing Drivers of Disease Behavior
onclive.com·23d ago
Johns Hopkins researchers honored for breakthrough in prostate cancer imaging technology
hub.jhu.edu·23d agoJohns Hopkins researchers honored for breakthrough in prostate cancer imaging technology
Johns Hopkins Magazine·23d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.